Dr. Carolyn F Deacon
Univ. Of Copenhagen
Dr Deacon earned her PhD at the University of Sheffield in the United Kingdom and completed two fellowships in gastrointestinal endocrinology, one at the Max-Planck-Institute in Göttingen, Germany, and the other at the University of Sheffield. She then took up at post-doctoral position at the University of Copenhagen in Denmark, supported initially by a Marie Curie fellowship from the European Union. She is now senior lecturer in the Department of Biomedical Sciences at the Panum Institute, University of Copenhagen, where she teaches undergraduate dental and medical students and is a supervisor of graduate and postgraduate students. In addition, she is a national faculty member of the PhD School of Molecular Metabolism in Denmark and a member of the editorial board of Diabetes. CardioRenal Medicine; and The Open Physiology Journal. Her current research interests centre on the degradation, metabolism and physiology of the enteropancreatic hormones and the therapeutic applications of the incretin hormones, GLP-1 analogues and DPP-4 inhibitors in the treatment of type 2 diabetes and the metabolic syndrome. Early studies investigating the metabolic stability of GLP-1, originating from her laboratory in the mid-1990s, have been instrumental in establishing the principle of using DPP-4 inhibition as a novel antihyperglycaemic therapy. Dr Deacon has authored more than 160 articles published in peer-reviewed journals, is a regular reviewer for papers submitted to journals in basic sciences, diabetes and endocrinology, and speaks at local, national and international scientific meetings.